Thore M, Jalakas K, Eriksson I, Dornbusch K
Department of Clinical Bacteriology, Central Hospital, Västerås, Sweden.
APMIS. 1989 Apr;97(4):317-24.
A modified disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa was evaluated. The amount of inducer was adapted to produce the smallest possible zone of inhibition and the distance between the centre of the disks was standardized. Among several beta-lactam antibiotic disks tested, imipenem (0.06 microgram per disk) or cefoxitin (10 micrograms per disk) placed at a distance of 14-16 mm from a cefotaxime disk (30 micrograms) most efficiently revealed inducible beta-lactamases. A positive induction test (primarily expected with Enterobacter spp, Citrobacter freundii, Serratia spp, Pseudomonas aeruginosa and indole positive Proteus spp) may serve as a warning of the risk of selecting mutants with beta-lactamase mediated cross-resistance during systemic treatment with ureidopenicillins, later generations of cephalosporins or monobactams. Such resistance was exemplified by characterization of some laboratory mutants with hyperproduction of beta-lactamases. However, evaluation of the specificity and sensitivity of the disk approximation test (and other indirect induction tests) still remains to be done.
对一种改良的用于检测肠杆菌科细菌和铜绿假单胞菌中诱导型β-内酰胺酶的纸片扩散近似试验进行了评估。诱导剂的用量进行了调整,以产生尽可能小的抑菌圈,并且纸片中心之间的距离进行了标准化。在测试的几种β-内酰胺抗生素纸片中,将亚胺培南(每片0.06微克)或头孢西丁(每片10微克)放置在距头孢噻肟纸片(30微克)14 - 16毫米的距离处,能最有效地检测出诱导型β-内酰胺酶。阳性诱导试验(主要见于肠杆菌属、弗氏柠檬酸杆菌、沙雷菌属、铜绿假单胞菌和吲哚阳性变形杆菌属)可能提示在使用脲基青霉素、新一代头孢菌素或单环β-内酰胺类药物进行全身治疗期间,选择具有β-内酰胺酶介导的交叉耐药突变体的风险。一些β-内酰胺酶高产的实验室突变体的特征就例证了这种耐药性。然而,纸片扩散近似试验(以及其他间接诱导试验)的特异性和敏感性评估仍有待进行。